Genpact (NYSE:G) issued an update on its FY 2021 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $2.400-$2.430 for the period, compared to the Thomson Reuters consensus estimate of $2.070. The company issued revenue guidance of $3.96 billion-$4 billion, compared to the consensus revenue estimate of $3.45 billion.
G traded up $0.43 on Thursday, reaching $50.76. The company’s stock had a trading volume of 511,964 shares, compared to its average volume of 1,152,117. The stock has a 50 day moving average of $49.60 and a two-hundred day moving average of $48.54. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $9.55 billion, a price-to-earnings ratio of 26.58, a P/E/G ratio of 1.63 and a beta of 1.39. Genpact has a fifty-two week low of $38.28 and a fifty-two week high of $52.75.
Genpact (NYSE:G) last issued its quarterly earnings data on Tuesday, November 9th. The business services provider reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.18. Genpact had a net margin of 9.52% and a return on equity of 24.89%. During the same quarter in the prior year, the firm posted $0.46 earnings per share. As a group, analysts anticipate that Genpact will post 2.11 earnings per share for the current fiscal year.
G has been the topic of a number of research analyst reports. JPMorgan Chase & Co. lifted their target price on Genpact from $55.00 to $61.00 and gave the stock an overweight rating in a research report on Tuesday, August 17th. Robert W. Baird raised their price target on Genpact from $58.00 to $60.00 and gave the stock an outperform rating in a research note on Tuesday, October 19th. They noted that the move was a valuation call. Deutsche Bank Aktiengesellschaft boosted their price objective on Genpact from $48.00 to $55.00 and gave the company a hold rating in a research note on Wednesday, November 10th. Finally, Needham & Company LLC raised their target price on shares of Genpact from $54.00 to $61.00 and gave the stock a buy rating in a research report on Friday, August 6th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Genpact has a consensus rating of Buy and an average price target of $55.80.
In other Genpact news, SVP Balkrishan Kalra sold 5,000 shares of Genpact stock in a transaction that occurred on Wednesday, September 15th. The stock was sold at an average price of $50.18, for a total value of $250,900.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 2.39% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the business. Citadel Advisors LLC lifted its stake in shares of Genpact by 3,776.4% in the third quarter. Citadel Advisors LLC now owns 47,525 shares of the business services provider’s stock valued at $2,258,000 after purchasing an additional 46,299 shares during the period. Morgan Stanley grew its position in Genpact by 25.2% during the second quarter. Morgan Stanley now owns 226,018 shares of the business services provider’s stock worth $10,267,000 after buying an additional 45,509 shares during the period. Finally, LPL Financial LLC increased its holdings in Genpact by 26.8% in the third quarter. LPL Financial LLC now owns 10,173 shares of the business services provider’s stock valued at $483,000 after buying an additional 2,152 shares in the last quarter. 97.14% of the stock is currently owned by institutional investors.
Genpact Company Profile
Genpact Ltd. engages in the business process management, outsourcing, shared services and information outsourcing. The company operates through the following segments: Banking, Capital Markets and Insurance (BCMI), Consumer Goods, Retail, Life Sciences, and Healthcare (CGRLH) and High Tech, Manufacturing, and Services (HMS).
Featured Article: Differences Between Momentum Investing and Long Term Investing
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.